Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHVF
Recent news which mentions RHHVF
< Previous
1
2
3
4
5
Next >
FDA Approves Expanded Use Of Roche's Influenza Treatment
August 12, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
News
From
Benzinga
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
August 08, 2022
Tickers
AMGN
MRK
RHHBF
RHHBY
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field
August 03, 2022
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
Penny Stocks
Trading Ideas
Benzinga
From
Benzinga
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
July 25, 2022
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Tickers
ABBV
ABUS
ASMB
HLVX
Tags
Contracts
VERV
ASMB
From
Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
July 21, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
Earnings
From
Benzinga
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test
July 18, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
Health Care
From
Benzinga
New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A
July 11, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
Health Care
From
Benzinga
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
July 06, 2022
Tickers
RHHBF
RHHBY
RHHVF
SRPT
Tags
Market News
Benzinga
Trading Ideas
From
Benzinga
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
July 06, 2022
Tickers
AMTI
BIIB
ESALF
ESALY
Tags
BIIB
EVOTF
Penny Stocks
From
Benzinga
Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients
June 16, 2022
Tickers
ACIU
RHHBF
RHHBY
RHHVF
Tags
Large Cap
Biotech
Health Care
From
Benzinga
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
June 06, 2022
Tickers
BNTX
MRK
RHHBF
RHHBY
Tags
MRK
Market News
Benzinga
From
Benzinga
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer
May 23, 2022
Tickers
MRK
RHHBF
RHHBY
RHHVF
Tags
Biotech
Health Care
MRK
From
Benzinga
Genentech's Tiragolumab/Tecentriq Fails On Progression Free Survival In PD-L1-High Metastatic Lung Cancer
May 11, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
RHHBY
General
From
Benzinga
Roche Releases More Evrysdi Data For Very Young Infants With SMA
April 29, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
News
Briefs
From
Benzinga
Roche's CEO Warns Russia-Ukraine War Causing Problems For Multiple Sclerosis Trials
April 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
Biotech
From
Benzinga
COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook
April 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Large Cap
Health Care
From
Benzinga
EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs
April 22, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Benzinga
RHHBF
RHHVF
From
Benzinga
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
April 20, 2022
Tickers
A
ILMN
MYGN
NTRA
Tags
Small Cap
Health Care
ILMN
From
Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
April 13, 2022
Tickers
PLRX
RHHBF
RHHBY
RHHVF
Tags
Movers
Briefs
why it's moving
From
Benzinga
Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis
April 04, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHVF
Benzinga
From
Benzinga
FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults
April 04, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Large Cap
Biotech
From
Benzinga
Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial
March 30, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
Benzinga
From
Benzinga
Drug makers, Scientists Working For Long COVID Treatments: Reuters
March 25, 2022
Tickers
AXLA
GSK
HGEN
MRNA
Tags
VIR
AXLA
Top Stories
From
Benzinga
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
March 16, 2022
Tickers
PTCT
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBF
Benzinga
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
Briefs
News
Hepatocellular Carcinoma
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
General
RHHBY
Phase 3 Trial
From
Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
Guidance
From
Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Earnings
NVS
News
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
General
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.